Although human T-ALL cell lines harboring NOTCH1 and PTEN mutations failed to respond to NOTCH inhibitors, primary murine T-ALLs were sensitive to such inhibitors21. This evidence concerns the gene PTEN and acute lymphoblastic leukemia.